Mixed connective tissue disease with protein-losing enteropathy: discussion of the treatment strategy

J Clin Rheumatol. 2011 Aug;17(5):286-7. doi: 10.1097/RHU.0b013e318227e836.

Authors

Chia-Ter Chao¹, Chun-Ying Lai, Pai-Ling Chang, Hau-Shin Wu, Vin-Cent Wu, Wei-Jie Wang

Affiliation

¹ Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei.

PMID: 21778905
DOI: 10.1097/RHU.0b013e318227e836

No abstract available

Publication types

Case Reports

MeSH terms

Administration, Oral
Adult
Antirheumatic Agents / administration & dosage
Antirheumatic Agents / therapeutic use
Azathioprine / administration & dosage
Azathioprine / therapeutic use*
Comorbidity
Cyclophosphamide / administration & dosage
Cyclophosphamide / therapeutic use*
Drug Therapy, Combination
Female
Humans
Infusions, Intravenous
Mixed Connective Tissue Disease / diagnosis
Mixed Connective Tissue Disease / drug therapy*
Mixed Connective Tissue Disease / epidemiology*
Protein-Losing Enteropathies / diagnosis
Protein-Losing Enteropathies / drug therapy*
Protein-Losing Enteropathies / epidemiology*
Treatment Outcome

Substances

Antirheumatic Agents
Cyclophosphamide
Azathioprine